Atara Biotherapeutics Depreciation & Amortization 2011-2026 | ATRA

Annual Depreciation & Amortization Atara Biotherapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
2.12 M	5.05 M	4.83 M	5.65 M	9.34 M	8.33 M	7.07 M	3.73 M	956 K	383 K	48 K	6 K	4 K	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
9.34 M	4 K	3.66 M

Quarterly Depreciation & Amortization Atara Biotherapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	1.8 M	-	600 K	700 K	1.39 M	-	900 K	900 K	1.21 M	-	1.1 M	1.4 M	1.59 M	-	2.3 M	2.3 M	2.22 M	-	2.2 M	2.1 M	1.95 M	-	1.8 M	1.8 M	1.65 M	-	1.2 M	700 K	333 K	-	300 K	200 K	206 K	-	100 K	100 K	15 K	-	21 K	11 K	6 K	-	4 K	2 K	1 K	-	3 K	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
2.3 M	1 K	946 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	63 K	-	10.36 %	$ 9.8 M	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Processa Pharmaceuticals PCSA	1.2 K	$ 2.37	1.72 %	$ 3.1 M	USA
Amphastar Pharmaceuticals AMPH	31.6 M	$ 19.6	1.92 %	$ 916 M	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Atreca BCEL	5.46 M	-	-11.76 %	$ 5.79 M	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	28 M	-	-	$ 546 M	USA
Cara Therapeutics CARA	259 K	-	-3.03 %	$ 260 M	USA
Phathom Pharmaceuticals PHAT	633 K	$ 10.35	2.88 %	$ 755 M	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Phio Pharmaceuticals Corp. PHIO	3 K	$ 1.27	4.09 %	$ 7.6 M	USA
Autolus Therapeutics plc AUTL	7.55 M	$ 1.35	1.89 %	$ 344 M	Britain
Corbus Pharmaceuticals Holdings CRBP	233 K	$ 8.23	0.61 %	$ 110 M	USA
CRISPR Therapeutics AG CRSP	19.5 M	$ 47.4	2.09 %	$ 4.26 B	Schweiz
Cyclacel Pharmaceuticals CYCC	6 K	-	-5.98 %	$ 34.1 M	USA
ChemoCentryx CCXI	3.14 M	-	-	$ 3.74 B	USA
Pliant Therapeutics PLRX	1.7 M	$ 1.32	3.13 %	$ 81 M	USA
PMV Pharmaceuticals PMVP	133 K	$ 1.39	-0.36 %	$ 73 M	USA
Dynavax Technologies Corporation DVAX	4.63 M	-	-	$ 2.02 B	USA
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
Enochian Biosciences ENOB	129 K	-	-	$ 40.5 M	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Prelude Therapeutics Incorporated PRLD	1.71 M	$ 3.26	4.49 %	$ 251 M	USA
Arbutus Biopharma Corporation ABUS	363 K	$ 4.51	4.76 %	$ 864 M	Canada
Homology Medicines FIXX	391 K	-	0.77 %	$ 53.4 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA